Literature DB >> 12814863

How specific are deficits in mismatch negativity generation to schizophrenia?

Daniel Umbricht1, René Koller, Liselotte Schmid, Anja Skrabo, Claudia Grübel, Theo Huber, Hans Stassen.   

Abstract

BACKGROUND: Mismatch negativity (MMN) is an auditory event-related potential that provides an index of auditory sensory memory. Deficits in MMN generation have been repeatedly demonstrated in chronic schizophrenia. Their specificity to schizophrenia has not been established.
METHODS: Mismatch negativity to both duration and frequency deviants was investigated in gender- and age-matched patients with schizophrenia or schizoaffective disorder (n = 26), bipolar disorder (n = 16), or major depression (n = 22) and healthy control subjects (n = 25).
RESULTS: Only patients with schizophrenia demonstrated significantly smaller mean MMN than did healthy control subjects. Detailed analyses showed significantly smaller MMN to both duration and frequency deviants in patients with schizophrenia than in healthy control subjects; however, the reduction of frequency MMN in patients with schizophrenia was not significant in the comparison across all groups. Mismatch negativity topography did not differ among groups. No consistent correlations with clinical, psychopathologic, or treatment variables were observed.
CONCLUSIONS: Mismatch negativity deficits, and by extension deficits in early cortical auditory information processing, appear to be specific to schizophrenia. Animal and human studies implicate dysfunctional N-methyl-D-aspartate receptor functioning in MMN deficits. Thus MMN deficits may become a useful endophenotype to investigate the genetic underpinnings of schizophrenia, particularly with regard to the N-methyl-D-aspartate receptor.

Entities:  

Mesh:

Year:  2003        PMID: 12814863     DOI: 10.1016/s0006-3223(02)01642-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  64 in total

1.  Delayed preattentional functioning in early psychosis patients with cannabis use.

Authors:  Nicole Pesa; Daniel F Hermens; Robert A Battisti; Manreena Kaur; Ian B Hickie; Nadia Solowij
Journal:  Psychopharmacology (Berl)       Date:  2012-03-09       Impact factor: 4.530

Review 2.  Translating glutamate: from pathophysiology to treatment.

Authors:  Daniel C Javitt; Darryle Schoepp; Peter W Kalivas; Nora D Volkow; Carlos Zarate; Kalpana Merchant; Mark F Bear; Daniel Umbricht; Mihaly Hajos; William Z Potter; Chi-Ming Lee
Journal:  Sci Transl Med       Date:  2011-09-28       Impact factor: 17.956

3.  Impaired Subcortical Detection of Auditory Changes in Schizophrenia but Not in Major Depression.

Authors:  Arnim Johannes Gaebler; Jana Zweerings; Jan Willem Koten; Andrea Anna König; Bruce I Turetsky; Mikhail Zvyagintsev; Klaus Mathiak
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

4.  Bi-directional modulation of somatosensory mismatch negativity with transcranial direct current stimulation: an event related potential study.

Authors:  Jui-Cheng Chen; Dorothea Hämmerer; Kevin D'Ostilio; Elias P Casula; Louise Marshall; Chon-Haw Tsai; John C Rothwell; Mark J Edwards
Journal:  J Physiol       Date:  2013-12-23       Impact factor: 5.182

5.  Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.

Authors:  Veronica B Perez; Neal R Swerdlow; David L Braff; Risto Näätänen; Gregory A Light
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 6.  Electrophysiological Endophenotypes for Schizophrenia.

Authors:  Emily M Owens; Peter Bachman; David C Glahn; Carrie E Bearden
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

7.  Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls.

Authors:  Anthony J Rissling; Sung-Hyouk Park; Jared W Young; Michelle B Rissling; Catherine A Sugar; Joyce Sprock; Daniel J Mathias; Marlena Pela; Richard F Sharp; David L Braff; Gregory A Light
Journal:  Schizophr Res       Date:  2013-03-11       Impact factor: 4.939

8.  Dysfunction in early auditory processing in major depressive disorder revealed by combined MEG and EEG.

Authors:  Seppo Kähkönen; Hidehisa Yamashita; Heikki Rytsälä; Kirsi Suominen; Jyrki Ahveninen; Erkki Isometsä
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

Review 9.  The endophenotype concept in psychiatric genetics.

Authors:  Jonathan Flint; Marcus R Munafò
Journal:  Psychol Med       Date:  2006-09-18       Impact factor: 7.723

10.  Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.

Authors:  Karsten Heekeren; Jörg Daumann; Anna Neukirch; Carsten Stock; Wolfram Kawohl; Christine Norra; Till D Waberski; Euphrosyne Gouzoulis-Mayfrank
Journal:  Psychopharmacology (Berl)       Date:  2008-05-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.